Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Phase 2    symbols : IGC    save search

IGC Commences Phase 2 Clinical Trials Evaluating Drug Candidate IGC-AD1 for the Treatment of Agitation in Dementia From Alzheimer’s Disease
Published: 2022-12-01 (Crawled : 13:20) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K twitter stocktwits trandingview |
Health Technology
| | O: 7.49% H: 3.07% C: -0.35%

treatment dementia trials drug candidate disease alzheimer’s phase 2
Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients
Published: 2021-12-02 (Crawled : 15:30) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 23.81% C: -0.79%

new drug alzheimer dementia drug trial phase 1 phase 2 alzheimer’s alzheimer's
IGC Completes its Phase 1 Clinical Trial on Alzheimer’s Patients, Reports Safety and Tolerability
Published: 2021-09-08 (Crawled : 14:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K twitter stocktwits trandingview |
Health Technology
| | O: 6.92% H: 1.76% C: -7.06%

alzheimer phase 1 trial phase 2 phase 3 alzheimer’s alzheimer's
IGC Completes the Final Cohort of its Phase 1 Clinical Trial on Alzheimer’s Patients
Published: 2021-06-24 (Crawled : 01:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K twitter stocktwits trandingview |
Health Technology
| | O: 17.57% H: 9.2% C: -5.17%

alzheimer phase 1 trial phase 2 phase 3 alzheimer’s alzheimer's
IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients
Published: 2021-06-09 (Crawled : 18:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K twitter stocktwits trandingview |
Health Technology
| | O: 0.64% H: 1.9% C: -5.7%

alzheimer phase 1 trial phase 3 phase 2 alzheimer’s alzheimer's
IGC Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients
Published: 2021-05-14 (Crawled : 14:00) - igcinc.us
IGC 4 | $0.49 2.92% 0.74% 610K twitter stocktwits trandingview |
Health Technology
| | O: 8.0% H: 3.7% C: 1.48%

alzheimer phase 1 trial phase 3 phase 2 alzheimer’s alzheimer's
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.